Goitre Market to Reach Significant Growth by 2035 – BIS Research

What Is Goitre? 

Goitre is an abnormal swelling of the thyroid gland at the base of the neck. It can result from iodine deficiency, autoimmune conditions (such as Hashimoto’s thyroiditis or Graves’ disease), or thyroid nodules. Symptoms may include visible neck swelling, difficulty swallowing, hoarseness, or even breathing challenges. The condition is closely linked with thyroid hormone imbalance, leading to either hypothyroidism (low hormone levels) or hyperthyroidism (excessive hormone levels). 

What Is the Market Outlook? 

Therapy Growth: Adoption of radioactive iodine (RAI) therapy, synthetic thyroid hormone replacement (Levothyroxine), and antithyroid drugs (Methimazole, Propylthiouracil) is expanding due to proven clinical efficacy. 

Preventive Push: Government-led iodine supplementation and fortification programs are significantly reducing iodine-deficiency-related goitre, especially in Asia-Pacific and Africa. 

Innovation in Care: Increased focus on personalized medicine, genetic testing, and biologics targeting thyroid signaling pathways is reshaping treatment protocols. 

How Fast Is the Market Growing? 

From 2025 to 2035, the goitre market is forecast to grow at a steady CAGR, fueled by rising prevalence, better diagnostic infrastructure, and improved treatment compliance. While exact figures vary by region, double-digit growth opportunities are anticipated in Asia-Pacific and other iodine-deficient regions. 

How Will This Report Help You? 

Planning to Enter the Market? 

Evaluate opportunities across hypothyroidism, hyperthyroidism, and iodine-deficiency-related treatments. 

Analyzing the Competitive Landscape? 

Gain insights into strategies from AbbVie, Pfizer, HanAll Biopharma, and Alora Pharmaceuticals. 

Seeking R&D Insights? 

Track the progress of biologic drugs, targeted therapies, and minimally invasive treatment alternatives. 

Interested in Regional Market Trends? 

Understand how healthcare infrastructure and public health initiatives drive adoption across North America, Europe, Asia-Pacific, and emerging economies. 

Download the Full TOC or Book a preview     

What Technologies Are Transforming the Market? 

• Radioactive Iodine Therapy (RAI) for Hyperthyroidism 
• Synthetic Thyroid Hormone Replacement (Levothyroxine) 
• Antithyroid Drugs (Methimazole, Propylthiouracil) 
• Genetic Testing for Personalized Care 
• Emerging Biologic Therapies Targeting Thyroid Pathways 

What’s Driving Demand, Opportunities, and Barriers? 

Demand Drivers 

• High prevalence of iodine deficiency and thyroid disorders worldwide 
• Growing awareness and early diagnosis of autoimmune thyroid diseases 
• Expansion of iodine fortification programs in developing regions 

Opportunities 

• Development of biologics with fewer side effects than current drugs 
• Untapped potential in Asia-Pacific, Latin America, and Africa 
• Increasing demand for personalized and genetic-based treatment 

Challenges 

• High costs of RAI and surgical interventions 
• Adverse side effects of antithyroid drugs (liver toxicity, skin rashes) 
• Lack of awareness and delayed diagnosis in underdeveloped regions 

Key Players 

• AbbVie 
• HanAll Biopharma 
• Pfizer Inc. 
• Alora Pharmaceuticals (Acella Pharmaceuticals, LLC) 

Strategic Developments 

• Expansion of iodine supplementation and salt iodization programs globally 
• R&D investment into targeted biologics and gene-driven therapies 
• Partnerships between pharmaceutical companies and public health organizations to reduce untreated cases 

 Download the complete TOC now! 

Case Study 

The report highlights successful iodine fortification programs in Asia-Pacific, which significantly reduced goitre prevalence among school-age children. Additionally, patient outcomes improved with early adoption of Levothyroxine and Methimazole therapies, ensuring better disease management and reducing long-term complications. 

Schedule a Call with Industry Experts  

Related Reports from BIS Research  

Gastric Cancer Market 

Orthopedic braces and Support Market 

Dermatomyositis Market 

About BIS Research  

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.    

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.     

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.    

Contact  

Head of Marketing   

Email: media@bisresearch.com     

BIS Research Inc.    

39111 PASEO PADRE PKWY STE 313,    

FREMONT, CA 94538-1686   

Visit our Blog @https://bisresearch.com/insights    

Get Expert Insights @https://community.insightmonk.com     

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research     

Connect with us on Twitter@ https://twitter.com/BISResearch    

Connect with us on Medium@ https://medium.com/@faisal.bis  

Connect with us on YouTube@ https://www.youtube.com/@BISResearchInc